Palisade bio to participate in the virtual investor closing bell series

Live video webcast on wednesday, june 26 th at 4:00 pm et carlsbad, ca, june 24, 2024 (globe newswire) -- palisade bio, inc. (nasdaq: pali) (“palisade” or the “company”), biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that it will participate in the virtual investor closing bell series on wednesday, june 26, 2024 at 4:00 pm et. as part of the event, j.d.
PALI Ratings Summary
PALI Quant Ranking